Fundamental dimension Equity attribute | BKYIPeer $3.49▲+27.37% Cap $5.01MP/E -0.9x QuantScore49/100 | BAERLeader $0.4912▲+4.38% Cap $28.90MP/E -0.7x QuantScore51/100 | CIGLPeer $0.2118▲+2.97% Cap $48.03MP/E -0.4x QuantScore11/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
77/100 |
45/100 |
24/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 48/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 25/100 | 11/100 | 19/100 |
Growth Revenue / earnings growth & margins | 41/100 | 67/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 83/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.9x | -0.7x | -0.4x |
Forward P/E (next FY) | -2.2x | -0.9x | — |
EV / EBITDA (TTM) | -1.3x | 10.4x | -3.5x |
Price / Sales | 0.7x | 0.3x | 3.8x |
Price / Free Cash Flow | -1.2x | -0.3x | -12.6x |
PEG ratio | -0.01 | 0.01 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 1 / 9 | — |
Altman Z-Score | -25.29 (Distress) | -1.39 (Distress) | — |
Total debt / equity | 0.03 | 7.81 | 1.43 |
Quick ratio | 1.1x | 1.7x | 1.3x |
Interest coverage | -16.7x | 0.0x | -51.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -12.0% | +24.6% | — |
Net income growth YoY | -6.7% | +126.6% | — |
Gross margin (TTM) | 81.7% | 38.1% | -78.4% |
Operating margin (FY) | -69.9% | 12.5% | -122.5% |
FCF margin (FY) | -76.7% | -52.3% | -30.5% |
5. Trailing price performancePrice change over period |
1M return | +66.2% | -40.8% | -48.7% |
3M return | -25.5% | -73.4% | -54.0% |
6M return | -44.3% | -76.9% | -86.2% |
Year to date | -37.1% | -73.2% | -86.8% |
1Y return | -56.0% | -71.8% | -92.3% |
3Y return | -90.1% | -90.9% | -95.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-64.87 -1958.7% premium | $-52.10 -10706.3% premium | $-4.14 -2054.0% premium |
Wall Street consensus target | — — | $3.67 +647.1% · range $3.00–$4.00 | — — |
Consensus stance | 100% Buy0% Hold0% Sell | 100% Buy0% Hold0% Sell | — |